Effect of endothelin receptor antagonist on the liver graft
Effect of endothelin receptor antagonist on the liver graft
批准号:
11671287
负责人:
YAMANAKA Jyunichi
金额:
$1.54万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2001
中文摘要
肝细胞癌(简称肝细胞癌)切除后预后有所改善。这项研究是为了确定影响无病生存时间的独立危险因素。用Knoell等人提出的组织学活动指数(HAI)评分对肝炎活动度进行分级。比例风险分析显示了以下结果。影响患者长期无复发生存的独立因素为年龄、吲哚青绿滞留率、肿瘤结节数、肿瘤包膜侵犯及门脉侵犯情况、HAI评分评价炎症活动。多变量分析证实,除了年龄、肝脏储备和肿瘤特征外,炎症活动的重要性也是复发的危险因素。要实现更长的无病生存,不仅要及早发现,而且要抑制并存的肝炎。
英文摘要
The prognosis hepatocellular carcinoma (HCC) has been improved after hepatic resection. This study was undertaken to determine independent risk factors affecting the length of disease-free survival. Activity of hepatitis was graded by the histological activity index (HAI) score, which was proposed by Knodell et al. Proportional hazard analysis demonstrated thefollowing results. The independent factors for long-term survival without recurrence were the patients' age, indocyanine green retention rate, number of tumor nodules, microscopic tumor capsular invasion and portal infiltration, and inflammatory activity assessed by HAI score. The importance of inflammatory activity in addition to aging, hepatic reserve and tumorcharacteristics was confirmed as a risk factor for recurrence by multivariate analysis. To achieve longer disease-free survival, not only early detection but also suppression of co-existing hepatitis is prerequisite.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Yamanaka J.: "Clinicopathologic analysis Stage II-III hepatocelllar carcinoma showing early Massive recurrence after liver resection."Journal of Gastroenterology and Hepatology. 15. 1192-1198 (2000)
Yamanaka J.:“临床病理学分析 II-III 期肝细胞癌显示肝切除后早期大量复发。”胃肠病学和肝脏病学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Naoki Yamanaka: "Viral serostatus and coexisting inflammatory activity affect metachronous carcinogenesis after hepatectomy for hepatocellular carcinoma"Journal of Gastroenterology. 35(3). 206-213 (2000)
Naoki Yamanaka:“病毒血清状态和共存的炎症活动影响肝细胞癌肝切除术后的异时致癌”胃肠病学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Masafumi Takata: "What patients can survive disease-free after complete resection for hepatocellular carcinoma? : A multivariate analysis"Japanese Journal of Clinical Oncology. 30(2). 75-81 (2000)
Masafumi Takata:“肝细胞癌完全切除后哪些患者可以无病生存?:多变量分析”日本临床肿瘤学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Naoki Yamanaka: "Viral serostatus and coexisting inflammatory activity affect metachronous carcinogenesis after hepatectomyfor hepatocellular carcinoma"Journal of Gastroenterology. (in press).
Naoki Yamanaka:“病毒血清状态和共存的炎症活动影响肝细胞癌肝切除术后的异时致癌”胃肠病学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Naoki Yamanaka: "Correlation of hepatitis virus serologic status with clinicopathologic features in patients undergoing hepatectomy for hepatocellular carcinoma"Cancer. 79(8). 1509-1515 (1997)
Naoki Yamanaka:“肝炎病毒血清学状态与因肝细胞癌接受肝切除术的患者临床病理特征的相关性”。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 11 条
海外基金